Androski Lindsay
SEC CIK 1936604 · EDGAR
Most active insiders at ABUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nguyen Tuan | CFO | — | — |
| 2 | Androski Lindsay | Pres, CEO, Dir | — | — |
| 3 | Sawhney Roger | Dir | — | — |
| 4 | Beardsley Robert A | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-23 20:32 | 2026-09-18 | ABUS | Arbutus Biopharma Corp | Androski Lindsay | Pres, CEO, Dir | M - OptEx | $3.30 | +126.9K | 154.9K | +453% | +$418.4K |
| D | 2026-09-23 20:32 | 2026-09-18 | ABUS | Arbutus Biopharma Corp | Androski Lindsay | Pres, CEO, Dir | F - Tax | $5.07 | -82.5K | 72.3K | -53% | -$418.4K |
| D | 2026-02-02 | 2026-02-02 | ABUS | Arbutus Biopharma Corp | Androski Lindsay | Pres, CEO, Dir | A - Grant | $0.00 | +28.0K | 28.0K | New | $0 |
| D | 2025-01-28 | 2025-01-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Androski Lindsay | Dir | M - OptEx | $0.00 | +3,750 | 15.8K | +31% | $0 |
| 2024-10-17 | 2024-10-16 | ELOX | Eloxx Pharmaceuticals, Inc. | Androski Lindsay | Dir | A - Grant | $0.00 | +12.0K | 12.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations